会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Extensible architecture for versioning APIs
    • 用于版本API的可扩展架构
    • US07610316B2
    • 2009-10-27
    • US10935350
    • 2004-09-07
    • Bradley J. BartzMichael R. SantoroChristopher G. KalerZachary L. AndersonChristopher D. Reeves
    • Bradley J. BartzMichael R. SantoroChristopher G. KalerZachary L. AndersonChristopher D. Reeves
    • G06F12/00G06F17/00G06F9/44
    • G06F8/60G06F9/44536Y10S707/99953Y10S707/99954
    • Some large software development projects need more than one versioning system to accommodate not only a diversity of document formats and data types, but also the geographic diversity of its programmers. However, having more than one versioning system is generally very expensive. A major factor in this expense is the requirement for a separate application program interface (API) for each separate versioning system. Accordingly, the inventors devised an exemplary API architecture that can be extended with “plug-in”protocol providers to include virtually any number of separate version stores or versioning systems. The exemplary architecture includes a generic command parser and a command dispatcher. The command dispatcher operatively couples to one or more protocol providers, each coupled to at least one version store. Inclusion of the OLE DB-compliant interface and the command parser in the exemplary embodiment saves the protocol providers the effort and expense of replicating these features, thereby reducing the cost of adding version stores.
    • 一些大型软件开发项目需要一个以上的版本控制系统,以适应文档格式和数据类型的多样性,同时也适应其程序员的地理多样性。 但是,拥有多个版本控制系统通常非常昂贵。 这个费用的一个主要因素是每个单独的版本控制系统需要一个单独的应用程序接口(API)。 因此,发明人设计了可以用“插件”协议提供者来扩展的示例性API架构,以实际包括任何数量的单独的版本存储或版本控制系统。 示例性架构包括通用命令解析器和命令分派器。 命令调度器可操作地耦合到一个或多个协议提供者,每个协议提供者耦合到至少一个版本存储。 在示例性实施例中包括OLE DB兼容接口和命令解析器保存协议提供者复制这些特征的努力和费用,从而降低添加版本存储的成本。
    • 6. 发明授权
    • Bioprocess for preparing 7-ACA and 7-ADAC
    • 用于制备7-ACA和7-ADAC的生物工艺
    • US5559005A
    • 1996-09-24
    • US250310
    • 1994-05-27
    • Michael J. ConderPhyllis C. McAdaJohn A. RambosekChristopher D. Reeves
    • Michael J. ConderPhyllis C. McAdaJohn A. RambosekChristopher D. Reeves
    • C12N1/19C07D501/20C12N1/15C12N9/00C12N9/02C12N9/10C12N15/09C12N15/52C12N15/54C12P20060101C12P35/00C12P35/06C12P37/04C12R1/82C12P35/04C12N1/16
    • C12N9/0071C12N9/00C12N9/1029C12P35/00C12P37/04Y10S435/935
    • Important intermediates for preparing cephalosporin antibiotics, 7-amino-cephalosporanic acid (7-ACA) and 7-aminodeacetylcephalosporanic acid (7-ADAC), are prepared by a novel bioprocess in which a transformed Penicillium chrysogenum strain is cultured in the presence of an adipate feedstock to produce adipoyl-6-APA (6-amino penicillanic acid); followed by the in situ expression of the following genes with which the P. chrysogenum has been transformed:1) an expandase gene, e.g., from Cephalosporium acremonium, whose expression product converts the adipoyl-6-APA by ring expansion to adipoyl-7-ADCA;2) an hydroxylase gene whose expression product converts the 3-methyl side chain of adipoyl-7-ADCA to 3-hydroxymethyl, to give the first product, 7-aminodeacetylcephalosporanic acid (7-ADAC); and3) an acetyltransferase gene whose expression product converts the 3-hydroxymethyl side chain to the 3-acetyloxymethyl side chain of 7-ACA. The final product, 7-ACA, is then prepared by cleavage of the adipoyl side chain using an adipoyl acylase. The entire synthesis, accordingly, is carried out using bioprocesses, and is efficient and economical.
    • 用于制备头孢菌素抗生素,7-氨基头孢菌素酸(7-ACA)和7-氨基脱乙酰头孢菌酸(7-ADAC)的重要中间体是通过新型生物工艺制备的,其中转化的产黄青霉菌株在己二酸存在下培养 生产己二酰-6-APA(6-氨基青霉烷酸)的原料; 其次是产生产黄青霉的以下基因的原位表达:1)扩增酶基因,例如头孢霉头孢菌,其表达产物通过环扩展将己二酰基-6-APA转化为己二酰-7- ADCA; 2)表达产物将己二酰-7-ADCA的3-甲基侧链转化为3-羟甲基的羟化酶基因,得到第一产物7-氨基乙酰基头孢烷酸(7-ADAC); 和3)其表达产物将3-羟甲基侧链转化为7-ACA的3-乙酰氧甲基侧链的乙酰转移酶基因。 然后通过使用己二酰酰化酶裂解己二酰侧链制备最终产物7-ACA。 因此,整个合成使用生物工艺进行,并且是高效和经济的。